What happened
Hyundai Pharmaceutical disclosed an acquisition of an individual, worth US$7.55M.
For context, this deal is worth about 6.9% of the company's own total assets.
| Target | an individual |
|---|---|
| Deal value | US$7.55M |
| vs. company assets | 6.9% |
| Filed | 2026-02-27, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260227801378 → open original filing |
Source: DART. Information only, not investment advice.